Laube B, Kuhse J, Betz H
Department of Neurochemistry, Max-Planck-Institute for Brain Research, 60528 Frankfurt/Main, Germany.
J Neurosci. 1998 Apr 15;18(8):2954-61. doi: 10.1523/JNEUROSCI.18-08-02954.1998.
The amino acids L-glutamate and glycine are essential agonists of the excitatory NMDA receptor, a subtype of the ionotropic glutamate receptor family. The native NMDA receptor is composed of two types of homologous membrane-spanning subunits, NR1 and NR2. Here, the numbers of glycine-binding NR1 and glutamate-binding NR2 subunits in the NMDA receptor hetero-oligomer were determined by coexpressing the wild-type (wt) NR1 with the low-affinity mutant NR1(Q387K), and the wt NR2B with the low-affinity mutant NR2BE387A, subunits in Xenopus oocytes. In both cases, analysis of the resulting dose-response curves revealed three independent components of glycine and glutamate sensitivity. These correspond to the respective wild-type and mutant affinities and an additional intermediate hybrid affinity, indicating the existence of three discrete receptor populations. Binomial analysis of these data indicates the presence of two glycine and two glutamate binding subunits in the functional receptor. In addition, we analyzed the inhibitory effects of the negative dominant NR1(R505K) and NR2BR493K mutants on maximal inducible whole-cell currents of wt NR1/NR2B receptors. The inhibition profiles obtained on expression of increasing amounts of these mutant proteins again were fitted best by assuming an incorporation of two NR1 and two NR2 subunits into the receptor hetero-oligomer. Our data are consistent with NMDA receptors being tetrameric proteins that are composed of four homologous subunits.
氨基酸L-谷氨酸和甘氨酸是兴奋性N-甲基-D-天冬氨酸(NMDA)受体的必需激动剂,NMDA受体是离子型谷氨酸受体家族的一个亚型。天然的NMDA受体由两种同源的跨膜亚基NR1和NR2组成。在这里,通过在非洲爪蟾卵母细胞中共表达野生型(wt)NR1与低亲和力突变体NR1(Q387K),以及wt NR2B与低亲和力突变体NR2B E387A亚基,确定了NMDA受体异源寡聚体中甘氨酸结合NR1亚基和谷氨酸结合NR2亚基的数量。在这两种情况下,对所得剂量反应曲线的分析揭示了甘氨酸和谷氨酸敏感性的三个独立成分。这些分别对应于各自的野生型和突变体亲和力以及一个额外的中间杂合亲和力,表明存在三个离散的受体群体。对这些数据的二项式分析表明,功能性受体中存在两个甘氨酸结合亚基和两个谷氨酸结合亚基。此外,我们分析了负显性NR1(R505K)和NR2B R493K突变体对wt NR1/NR2B受体最大诱导全细胞电流的抑制作用。通过假设将两个NR1亚基和两个NR2亚基掺入受体异源寡聚体中,再次对随着这些突变蛋白表达量增加而获得的抑制曲线进行了最佳拟合。我们的数据与NMDA受体是由四个同源亚基组成的四聚体蛋白一致。